Suven Life Sciences (Suven) has secured one product patent from Brazil and one product patent from Eurasia corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2023 and 2034 respectively. The granted claims of the patents include the class …
Read More »Tag Archives: suven life sciences share price target
Suven Life Sciences secures product patents in Australia, Hong Kong
Suven Life Science has secured one product patent from Australia and one product patent from Hong Kong corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2033 respectively. The granted claims of the patents include the class …
Read More »